Endometriosis and ovarian cancer

A review

Nikos F. Vlahos, Theodoros Kalampokas, Stylianos Fotiou

    Research output: Contribution to journalArticle

    Abstract

    Objectives. To describe the relationship between endometriosis and ovarian cancer. Search strategy. Review of the relevant clinical, epidemiologic, and molecular biology literature. Selection criteria. Studies published in the English language using the MEDLINE database. Data collection and analysis. Relevant studies were reviewed by the three authors and those that seem to be of significant scientific value, based on the methodology and statistical power, were included. Main results. Endometriosis and ovarian cancer share many common predisposing factors. Both conditions demonstrate similar patterns regarding local invasion and distal spread they respond similarly to estrogen-induced growth signaling, they express resistance to apoptotic mechanisms and they are characterized by genomic instability. Endometrioid and clear-cell are the most frequent types of ovarian cancer associated with endometriosis. Tubal ligation, in women with endometriosis, seems to prevent retrograde menstruation but it has also been shown to be protective from these types of ovarian cancer. Conclusion. There is evidence to support that endometriosis (by definition a benign process), could simultaneously have the potential for malignant transformation. More studies are needed to establish risk factors that may lead to malignant transformation of this condition and to identify predisposed individuals who may require closer surveillance.

    Original languageEnglish (US)
    Pages (from-to)213-219
    Number of pages7
    JournalGynecological Endocrinology
    Volume26
    Issue number3
    DOIs
    StatePublished - 2010

    Fingerprint

    Endometriosis
    Ovarian Neoplasms
    Menstruation Disturbances
    Tubal Sterilization
    Genomic Instability
    MEDLINE
    Causality
    Patient Selection
    Molecular Biology
    Estrogens
    Language
    Databases
    Growth

    Keywords

    • Cancer
    • Endometriosis
    • Infertility
    • K-ras
    • Ovary
    • PTEN

    ASJC Scopus subject areas

    • Endocrinology
    • Endocrinology, Diabetes and Metabolism
    • Obstetrics and Gynecology

    Cite this

    Endometriosis and ovarian cancer : A review. / Vlahos, Nikos F.; Kalampokas, Theodoros; Fotiou, Stylianos.

    In: Gynecological Endocrinology, Vol. 26, No. 3, 2010, p. 213-219.

    Research output: Contribution to journalArticle

    Vlahos, NF, Kalampokas, T & Fotiou, S 2010, 'Endometriosis and ovarian cancer: A review', Gynecological Endocrinology, vol. 26, no. 3, pp. 213-219. https://doi.org/10.3109/09513590903184050
    Vlahos, Nikos F. ; Kalampokas, Theodoros ; Fotiou, Stylianos. / Endometriosis and ovarian cancer : A review. In: Gynecological Endocrinology. 2010 ; Vol. 26, No. 3. pp. 213-219.
    @article{1d4e5d2a45ef40a3928fc64ad65150ef,
    title = "Endometriosis and ovarian cancer: A review",
    abstract = "Objectives. To describe the relationship between endometriosis and ovarian cancer. Search strategy. Review of the relevant clinical, epidemiologic, and molecular biology literature. Selection criteria. Studies published in the English language using the MEDLINE database. Data collection and analysis. Relevant studies were reviewed by the three authors and those that seem to be of significant scientific value, based on the methodology and statistical power, were included. Main results. Endometriosis and ovarian cancer share many common predisposing factors. Both conditions demonstrate similar patterns regarding local invasion and distal spread they respond similarly to estrogen-induced growth signaling, they express resistance to apoptotic mechanisms and they are characterized by genomic instability. Endometrioid and clear-cell are the most frequent types of ovarian cancer associated with endometriosis. Tubal ligation, in women with endometriosis, seems to prevent retrograde menstruation but it has also been shown to be protective from these types of ovarian cancer. Conclusion. There is evidence to support that endometriosis (by definition a benign process), could simultaneously have the potential for malignant transformation. More studies are needed to establish risk factors that may lead to malignant transformation of this condition and to identify predisposed individuals who may require closer surveillance.",
    keywords = "Cancer, Endometriosis, Infertility, K-ras, Ovary, PTEN",
    author = "Vlahos, {Nikos F.} and Theodoros Kalampokas and Stylianos Fotiou",
    year = "2010",
    doi = "10.3109/09513590903184050",
    language = "English (US)",
    volume = "26",
    pages = "213--219",
    journal = "Gynecological Endocrinology",
    issn = "0951-3590",
    publisher = "Informa Healthcare",
    number = "3",

    }

    TY - JOUR

    T1 - Endometriosis and ovarian cancer

    T2 - A review

    AU - Vlahos, Nikos F.

    AU - Kalampokas, Theodoros

    AU - Fotiou, Stylianos

    PY - 2010

    Y1 - 2010

    N2 - Objectives. To describe the relationship between endometriosis and ovarian cancer. Search strategy. Review of the relevant clinical, epidemiologic, and molecular biology literature. Selection criteria. Studies published in the English language using the MEDLINE database. Data collection and analysis. Relevant studies were reviewed by the three authors and those that seem to be of significant scientific value, based on the methodology and statistical power, were included. Main results. Endometriosis and ovarian cancer share many common predisposing factors. Both conditions demonstrate similar patterns regarding local invasion and distal spread they respond similarly to estrogen-induced growth signaling, they express resistance to apoptotic mechanisms and they are characterized by genomic instability. Endometrioid and clear-cell are the most frequent types of ovarian cancer associated with endometriosis. Tubal ligation, in women with endometriosis, seems to prevent retrograde menstruation but it has also been shown to be protective from these types of ovarian cancer. Conclusion. There is evidence to support that endometriosis (by definition a benign process), could simultaneously have the potential for malignant transformation. More studies are needed to establish risk factors that may lead to malignant transformation of this condition and to identify predisposed individuals who may require closer surveillance.

    AB - Objectives. To describe the relationship between endometriosis and ovarian cancer. Search strategy. Review of the relevant clinical, epidemiologic, and molecular biology literature. Selection criteria. Studies published in the English language using the MEDLINE database. Data collection and analysis. Relevant studies were reviewed by the three authors and those that seem to be of significant scientific value, based on the methodology and statistical power, were included. Main results. Endometriosis and ovarian cancer share many common predisposing factors. Both conditions demonstrate similar patterns regarding local invasion and distal spread they respond similarly to estrogen-induced growth signaling, they express resistance to apoptotic mechanisms and they are characterized by genomic instability. Endometrioid and clear-cell are the most frequent types of ovarian cancer associated with endometriosis. Tubal ligation, in women with endometriosis, seems to prevent retrograde menstruation but it has also been shown to be protective from these types of ovarian cancer. Conclusion. There is evidence to support that endometriosis (by definition a benign process), could simultaneously have the potential for malignant transformation. More studies are needed to establish risk factors that may lead to malignant transformation of this condition and to identify predisposed individuals who may require closer surveillance.

    KW - Cancer

    KW - Endometriosis

    KW - Infertility

    KW - K-ras

    KW - Ovary

    KW - PTEN

    UR - http://www.scopus.com/inward/record.url?scp=77249095032&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=77249095032&partnerID=8YFLogxK

    U2 - 10.3109/09513590903184050

    DO - 10.3109/09513590903184050

    M3 - Article

    VL - 26

    SP - 213

    EP - 219

    JO - Gynecological Endocrinology

    JF - Gynecological Endocrinology

    SN - 0951-3590

    IS - 3

    ER -